menu search

BLCM / Bellicum (BLCM) Down on Ending Development of CAR-T Candidates

Bellicum (BLCM) Down on Ending Development of CAR-T Candidates
Following the decision to discontinue the development of pipeline candidates, Bellicum Pharmaceuticals (BLCM) is left with no candidate in clinical development. The stock is down 50% post the news. Read More
Posted: Mar 16 2023, 13:00
Author Name: Zacks Investment Research
Views: 103065

BLCM News  

Bellicum (BLCM) Down on Ending Development of CAR-T Candidates

By Zacks Investment Research
March 16, 2023

Bellicum (BLCM) Down on Ending Development of CAR-T Candidates

Following the decision to discontinue the development of pipeline candidates, Bellicum Pharmaceuticals (BLCM) is left with no candidate in clinical de more_horizontal

Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
February 27, 2023

Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?

Here is how Bellicum Pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this year. more_horizontal


Search within

Pages Search Results: